Prognostic factors and predictors of sorafenib benefit in patients with hepatocellular carcinoma: Analysis of two phase III studies

Bruix J, Cheng AL, Meinhardt G, Nakajima K, De Sanctis Y, Llovet J
 
J Hepatol   2017